Key result
Intensified antihypertensive and insulin therapy fails to improve GFR in overt diabetic nephropathy.
Why the study?
The effect of continuous tight blood pressure control and intensified insulin therapy on progression of renal failure in patients with overt diabetic nephropathy and impaired renal function was investigated.
Does continuous tight blood pressure control and intensified insulin therapy prevent progression of renal failure in hypertensive type 1 diabetic patients with overt diabetic nephropathy?
RCT (n=39)
Open-label
Randomized allocation
Yes
Does continuous tight blood pressure control and intensified insulin therapy prevent progression of renal failure in hypertensive type 1 diabetic patients with overt diabetic nephropathy?
Mean Difference: 1.9 (95% CI -2.2–6.1)
Intensified blood pressure and insulin therapy can stabilize glomerular filtration rate over 2 years in type 1 diabetic patients with overt nephropathy and impaired renal function.
May support tight BP/insulin intensification in type 1 diabetic nephropathy with low GFR; leaves open need for randomized confirmation.
OBJECTIVES: We investigated the effect of achieved continuous tight blood pressure control and intensified insulin therapy on the rate of progression of renal failure in patients with overt diabetic nephropathy and already impaired renal function. DESIGN AND SETTING: Prospective, randomized, multicentre, follow-up study. PATIENTS AND INTERVENTIONS: From a screened group of the 66 hypertensive type 1 diabetic patients (IDDM) with overt diabetic nephropathy and reduced glomerular filtration rate who participated in two intensified treatment programmes, 39 patients fulfilled the study inclusion criteria and were enrolled into the 2-year follow-up period. The choice of antihypertensive drugs was based on a randomized allocation to open antihypertensive treatments starting with felodipine, metoprolol, or ramipril. OUTCOME MEASURES: Progression of renal failure was assessed by measurement of glomerular filtration rate (GFR) on insulin clearance every 6 months. MAIN RESULTS: During the study period mean HbA1c was 8.1 +/- 1.6% and the office blood pressure 143 +/- 14/88 +/- 8 mmHg. The change in GFRinulin (mean and 95% CI) was +1.9 (-2.2; +6.1) ml/min/year. GFR improved in 51%, deteriorated in 39%, and remained stable in 10% of the patients. CONCLUSION: This study shows that stabilization of glomerular filtration rate, as assessed by inulin clearance, is possible in patients with overt diabetic nephropathy who reach the goals of intensified antihypertensive treatment even if kidney function is already impaired.
No takes yet. Share an insight, caveat, or question.
A 1997 study conducted an RCT in Diabetic nephropathy (n=39). Intensified antihypertensive treatment (felodipine, metoprolol, or ramipril) and insulin therapy was evaluated on Progression of renal failure assessed by measurement of glomerular filtration rate (GFR) on inulin clearance (mean change +1.9 ml/min/year, 95% CI -2.2 to +6.1). Intensified antihypertensive and insulin therapy in patients with overt diabetic nephropathy resulted in a mean change in glomerular filtration rate of +1.9 ml/min/year (95% CI -2.2 to +6.1).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: